These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 18788852)
1. Clear cell adenocarcinoma of urinary bladder and urethra: another urinary tract lesion immunoreactive for P504S. Sun K; Huan Y; Unger PD Arch Pathol Lab Med; 2008 Sep; 132(9):1417-22. PubMed ID: 18788852 [TBL] [Abstract][Full Text] [Related]
2. Hepatocyte nuclear factor-1β expression in clear cell adenocarcinomas of the bladder and urethra: diagnostic utility and implications for histogenesis. Brimo F; Herawi M; Sharma R; Netto GJ; Epstein JI; Illei PB Hum Pathol; 2011 Nov; 42(11):1613-9. PubMed ID: 21496868 [TBL] [Abstract][Full Text] [Related]
3. Expression of alpha-methylacyl-CoA racemase (P504S) in nephrogenic adenoma: a significant immunohistochemical pitfall compounding the differential diagnosis with prostatic adenocarcinoma. Skinnider BF; Oliva E; Young RH; Amin MB Am J Surg Pathol; 2004 Jun; 28(6):701-5. PubMed ID: 15166661 [TBL] [Abstract][Full Text] [Related]
4. Clear cell carcinoma of the urinary bladder: a report and comparison of four tumors of mullerian origin and nine of probable urothelial origin with discussion of histogenesis and diagnostic problems. Oliva E; Amin MB; Jimenez R; Young RH Am J Surg Pathol; 2002 Feb; 26(2):190-7. PubMed ID: 11812940 [TBL] [Abstract][Full Text] [Related]
5. Clear cell adenocarcinoma and nephrogenic adenoma of the urethra and urinary bladder: a histopathologic and immunohistochemical comparison. Gilcrease MZ; Delgado R; Vuitch F; Albores-Saavedra J Hum Pathol; 1998 Dec; 29(12):1451-6. PubMed ID: 9865832 [TBL] [Abstract][Full Text] [Related]
6. Nephrogenic adenoma: immunohistochemical evaluation for its etiology and differentiation from prostatic adenocarcinoma. Xiao GQ; Burstein DE; Miller LK; Unger PD Arch Pathol Lab Med; 2006 Jun; 130(6):805-10. PubMed ID: 16740031 [TBL] [Abstract][Full Text] [Related]
7. Histology and immunohistochemistry of clear cell adenocarcinoma of the urethra: histogenesis and diagnostic problems. Alexiev BA; Tavora F Virchows Arch; 2013 Feb; 462(2):193-201. PubMed ID: 23307189 [TBL] [Abstract][Full Text] [Related]
9. Expression of alpha-methylacyl-CoA racemase in vaginal gastric-type adenocarcinoma and uterine clear cell carcinoma. Hu J; Lu Y; Tang N; Li L; Guo P; Zhang Y Indian J Pathol Microbiol; 2020; 63(1):49-52. PubMed ID: 32031122 [TBL] [Abstract][Full Text] [Related]
10. Expression and diagnostic utility of alpha-methylacyl-CoA-racemase (P504S) in foamy gland and pseudohyperplastic prostate cancer. Zhou M; Jiang Z; Epstein JI Am J Surg Pathol; 2003 Jun; 27(6):772-8. PubMed ID: 12766580 [TBL] [Abstract][Full Text] [Related]
11. Clear cell adenocarcinoma of the bladder and urethra: cases diffusely mimicking nephrogenic adenoma. Herawi M; Drew PA; Pan CC; Epstein JI Hum Pathol; 2010 Apr; 41(4):594-601. PubMed ID: 20060152 [TBL] [Abstract][Full Text] [Related]
12. Expression of alpha-Methylacyl-CoA racemase (P504S) in atypical adenomatous hyperplasia of the prostate. Yang XJ; Wu CL; Woda BA; Dresser K; Tretiakova M; Fanger GR; Jiang Z Am J Surg Pathol; 2002 Jul; 26(7):921-5. PubMed ID: 12131160 [TBL] [Abstract][Full Text] [Related]
13. Primary seminal vesicle carcinoma: an immunohistochemical analysis of four cases. Ormsby AH; Haskell R; Jones D; Goldblum JR Mod Pathol; 2000 Jan; 13(1):46-51. PubMed ID: 10658909 [TBL] [Abstract][Full Text] [Related]
14. Utility of a triple antibody cocktail intraurothelial neoplasm-3 (IUN-3-CK20/CD44s/p53) and α-methylacyl-CoA racemase (AMACR) in the distinction of urothelial carcinoma in situ (CIS) and reactive urothelial atypia. Aron M; Luthringer DJ; McKenney JK; Hansel DE; Westfall DE; Parakh R; Mohanty SK; Balzer B; Amin MB Am J Surg Pathol; 2013 Dec; 37(12):1815-23. PubMed ID: 24225842 [TBL] [Abstract][Full Text] [Related]
15. Expression of alpha-methylacyl-CoA racemase correlates with histopathologic grading in noninvasive bladder cancer. Gunia S; May M; Scholmann K; Störkel S; Hoschke B; Koch S; Dietel M; Kristiansen G Virchows Arch; 2008 Aug; 453(2):165-70. PubMed ID: 18648853 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic utility of a p63/alpha-methyl-CoA-racemase (p504s) cocktail in atypical foci in the prostate. Molinié V; Fromont G; Sibony M; Vieillefond A; Vassiliu V; Cochand-Priollet B; Hervé JM; Lebret T; Baglin AC Mod Pathol; 2004 Oct; 17(10):1180-90. PubMed ID: 15205683 [TBL] [Abstract][Full Text] [Related]
17. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens. Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468 [TBL] [Abstract][Full Text] [Related]
18. [Pathological and immunohistochemical analyses of 32 cases of nephrogenic adenoma]. Shen Q; Sun LH; Wang JH; Liu LB; He Q; Jin J Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Aug; 45(4):522-6. PubMed ID: 23939154 [TBL] [Abstract][Full Text] [Related]
19. [Value of the antibody cocktail anti p63 + anti p504s for the diagnosis of prostatic cancer]. Molinié V; Hervé JM; Lebret T; Lugagne-Delpon PM; Saporta F; Yonneau L; Botto H; Baglin AC Ann Pathol; 2004 Feb; 24(1):6-16. PubMed ID: 15192532 [TBL] [Abstract][Full Text] [Related]